Chronic Pain Treatment Options: From Medication to Spinal Cord Stimulation

50 Million Americans Living with Pain That Will Not Stop

The CDC's 2019 National Health Interview Survey found that 20.4% of U.S. adults — approximately 50 million people — experienced chronic pain (pain on most days or every day during the past 6 months), and 7.4% had high-impact chronic pain that substantially restricted daily activities. Chronic pain is the leading cause of disability in the United States and costs the economy an estimated $560–$635 billion annually in medical expenses and lost productivity. Unlike acute pain, which signals tissue damage and resolves with healing, chronic pain persists beyond expected tissue healing time and frequently involves central sensitization — structural and functional changes in the spinal cord and brain that amplify pain signals independent of peripheral input.

Pain outlives injury. That distinction shapes everything about treatment.

Classification Guides Treatment

Chronic pain is not a single condition but an umbrella covering mechanistically distinct entities that often require different treatment approaches.

Non-Pharmacological Interventions: The Foundation

Exercise is medicine. Multiple systematic reviews confirm that supervised exercise therapy reduces chronic pain intensity and improves function across diverse conditions including chronic low back pain (effect size ~0.7 for pain reduction), fibromyalgia, and osteoarthritis. The analgesic mechanisms involve endogenous opioid and endocannabinoid release, reduced central sensitization, and improved muscle strength reducing joint load.

Cognitive behavioral therapy (CBT) for chronic pain addresses the cognitive and emotional factors that amplify pain perception and disability. A 2021 Cochrane review of CBT for chronic low back pain found moderate-quality evidence for clinically meaningful reductions in pain intensity and disability at short-term follow-up. CBT is particularly effective when combined with physical rehabilitation in a multidisciplinary pain program.

Key non-pharmacological options:

• Physical therapy: Targeted exercise, manual therapy, and graded activity for most chronic musculoskeletal pain conditions; first-line for chronic low back and neck pain per ACP guidelines
• Cognitive behavioral therapy (CBT): Addresses catastrophizing, fear-avoidance behavior, and pain-related distress; evidence-based across multiple chronic pain conditions
• Mindfulness-based stress reduction (MBSR): Shown in RCTs to reduce pain-related distress and improve function; effect sizes moderate
• Transcutaneous electrical nerve stimulation (TENS): Low-risk, modest evidence for musculoskeletal pain; suitable as adjunct
• Acupuncture: A 2018 individual patient data meta-analysis in the Journal of Pain (29 RCTs, 17,922 patients) found acupuncture superior to both sham and no-acupuncture control for back/neck pain, headache, shoulder pain, and osteoarthritis

Pharmacological Treatment by Pain Type

Drug selection depends heavily on pain mechanism. Treating neuropathic pain with NSAIDs alone is largely ineffective; treating nociplastic pain with opioids is both ineffective and harmful.

Neuropathic pain first-line agents:

• Tricyclic antidepressants (TCAs: amitriptyline, nortriptyline): NNT approximately 3.6 for 50% pain relief; limited by anticholinergic side effects and cardiac risk in older adults
• SNRIs (duloxetine, venlafaxine): NNT approximately 5–6; duloxetine FDA-approved for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain
• Gabapentinoids (gabapentin, pregabalin): NNT approximately 6–7 for neuropathic pain; pregabalin FDA-approved for PHN, diabetic neuropathy, fibromyalgia, and spinal cord injury pain; risk of misuse and respiratory depression, especially with opioids
• Topical lidocaine (5% patch): effective for localized neuropathic pain, excellent tolerability
• Capsaicin 8% patch (Qutenza): TRPV1 channel depletion; single application provides up to 3 months of relief for PHN and peripheral neuropathic pain

Interventional Pain Management

When medications and physical therapies are insufficient, interventional procedures can provide targeted pain relief or guide rehabilitation.

Spinal Cord Stimulation

Spinal cord stimulation (SCS) delivers low-level electrical impulses to the dorsal columns of the spinal cord via surgically implanted electrodes, modulating pain signal transmission. Traditional SCS (tonic stimulation, 50–100 Hz) produces paresthesia at the pain location; high-frequency (10 kHz) and burst stimulation modes suppress pain without paresthesia, improving acceptance and efficacy.

The PROCESS trial for failed back surgery syndrome and ACCURATE trial comparing SCS modalities established SCS as superior to continued medical management for appropriate candidates. High-frequency (10 kHz) SCS (HF10 therapy, Nevro) showed approximately 80% responder rates (>50% pain relief) at 12 months in the SENZA-RCT, compared to approximately 55% for traditional SCS. SCS is FDA-approved for failed back surgery syndrome, complex regional pain syndrome, and chronic intractable pain of the trunk and limbs. The procedure requires a trial period (external stimulator for 5–7 days) before permanent implantation.

This article is for informational purposes only. Consult a qualified healthcare professional before making medical decisions.